The forecast for respiratory system medicine use in Norway shows a steady year-on-year increase. From 2024 to 2025, usage is expected to grow by approximately 3.4%, followed by an increase of around 3.3% in 2026, 3.1% in 2027, and 3.0% in 2028. The average compound annual growth rate (CAGR) over the five-year period is 3.2%, indicating consistent growth. In 2023, the usage stood at 263.5 units per thousand persons per day. The past years have seen an upward trend, reflecting an increasing demand for respiratory system medicines.
Future trends to watch for include potential changes in regulations, advancements in medical technology, and the impact of environmental factors such as pollution and climate change on respiratory health. Additionally, demographic shifts such as an aging population may drive further increases in medication usage.
